Revefenacin
0180
Approved small_molecule completed
Quick answer
Revefenacin for Chronic Obstructive Pulmonary Disease is a Approved program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Chronic Obstructive Pulmonary Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed